NR4A1 and triple-negative breast carcinoma: In breast cancer, gPALB2 mutations confer a higher risk of various breast cancer subtypes including hormone receptor-positive, HER2-positive and triple-negative breast cancer, in proportions similar to those seen with gBRCA2 mutations48.